U. Karck

451 citations
20 papers · 368 indexed · h-index 11

U. Karck

17 papers receiving 358 citations

Peers

U. Karck
Comparison fields: 5 of 79
  • Hepatology 50
  • Pharmacology 45
  • Reproductive Medicine 43
  • Immunology 82
  • Biochemistry 28
Replace I Harman with:
I Harman United States
Peihao Liu China
Dasheng Xu Canada
Rajani Kaimal United States
Tadaki Yasumura Japan
Gordon S. Baskin United States
BYRON U. MUSA United States
Xiaojing Zhang China
Catherine Shearing United Kingdom
U. Karck relative to I Harman United States I Harman's profile →
Citations per field
00.5×3.3×
I Harman · 1×
Citations per year

Countries citing papers authored by U. Karck

Since Specialization
Citations

This map shows the geographic impact of U. Karck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Karck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Karck more than expected).

Fields of papers citing papers by U. Karck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Karck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Karck. The network helps show where U. Karck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside U. Karck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with U. Karck Line = papers co-authored together U. Karck links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200841
2 200616
3 20049
4
Prospektive, offene multizentrische Phase-IV-Studie zur Wirksamkeit und Verträglichkeit von Tibolon bei postmenopausalen Beschwerden
20031
5 200323
6 200211
7 20020
8 20010
9 200014
10 20003
11 19971
12 199524
13 199419
14 199422
15 19933
16
[Gonadotropin-releasing hormone (GnRH) and its analogs in current medicine].
19921
17 19911
18 1988108
19 198743
20 198728

About U. Karck

U. Karck is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Biochemistry, having authored 20 papers that have together received 368 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Maternal and fetal healthcare (2 papers), Reproductive Health and Contraception (2 papers), Cancer, Lipids, and Metabolism (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Immune Response and Inflammation (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Hepatology (50 citations), Pharmacology (45 citations) and Reproductive Medicine (43 citations). U. Karck has collaborated with scholars based in Germany, Switzerland and Czechia. Frequent co-authors include K. Decker, H.‐J. Schlayer, H. Laaff, Hans E. Schaefer, E. Merkle, Thomas Peters, Cosima Brucker, Agnes Schulze‐Specking, Peter Dieter and Christoph Keck. Their work appears in journals such as Journal of Hepatology, European Journal of Biochemistry, European Journal of Cancer, Gynecologic Oncology and Prostaglandins Leukotrienes and Essential Fatty Acids.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026